A total of 127 institutions worldwide made this round's ESI Immunology top 1‰ list, including seven universities from the Chinese mainland. HUST ranks 125th among global institutions and 7th among mainland Chinese universities. Meanwhile, HUST's overall ESI ranking stands at 51st among all global institutions and 31st among global universities.
The rise has been a decade in the making. HUST's global ESI ranking in Immunology has climbed steadily, from 545th in November 2015, to 268th in 2021, 171st in 2024, and now 125th in November 2026.
What does ESI Immunology cover?
The field spans:
cellular and molecular immunology research,
clinical immunopathology,
infectious diseases,
autoimmunity and allergies,
host–pathogen interactions,
and experimental therapeutic applications of immunomodulators,
drawing from leading academic journals across these areas.
A university-wide effort
The achievement was driven by joint efforts across Tongji Hospital, Union Hospital, the School of Basic Medicine, the Institute of Reproductive Health, the School of Public Health, the College of Life Science and Technology, the School of Medicine and Health Management, the School of Pharmacy, Liyuan Hospital, and Wuhan National Laboratory for Optoelectronics (WNLO), etc.
Congratulations to every researcher, clinician, and student whose work made this possible!